Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RLP 068

Drug Profile

RLP 068

Alternative Names: RLP068; RLP068/Cl; VULNOFAST; VULNOFAST Gel; VULNOFAST Plus

Latest Information Update: 21 Jul 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Molteni Therapeutics
  • Class Antibacterials; Antifungals; Phthalocyanines; Small molecules
  • Mechanism of Action Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Skin ulcer; Wound infections

Most Recent Events

  • 27 Jul 2010 Phase-II clinical trials in Wound infections in Italy (Topical)
  • 27 Aug 2007 Preclinical development is ongoing
  • 27 Aug 2007 Molteni Therapeutics seeks partnerships to further develop candidates from this research programme
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top